Mechlorethamine based Drug Structures for Intervention of Central Nervous System Tumors

E-ISSN： 1875-6166|13|2|114-121

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.13, Iss.2, 2013-06, pp. : 114-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug-Resistance in Central Nervous System Tumors: From the Traditional Cell-Resistance Model to the Genetically Driven Approaches on Therapy

Current Pharmaceutical Biotechnology, Vol. 8, Iss. 2, 2007-04 ,pp. : 105-113

Bentham Science Publishers

Access to resources Recommend Favorite

The MYCN Oncogene as a Specific and Selective Drug Target for Peripheral and Central Nervous System Tumors

Current Cancer Drug Targets, Vol. 5, Iss. 4, 2005-06 ,pp. : 273-283

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokines in the Central Nervous System: Targets for Therapeutic Intervention

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 4, 2004-08 ,pp. : 271-280

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-HIV Drug Distribution to the Central Nervous System

Current Pharmaceutical Design, Vol. 10, Iss. 12, 2004-05 ,pp. : 1313-1324

Bentham Science Publishers

Access to resources Recommend Favorite

Current Approaches for Drug Delivery to Central Nervous System

Current Drug Delivery, Vol. 7, Iss. 5, 2010-12 ,pp. : 389-397

Bentham Science Publishers

Access to resources Recommend Favorite